Latest news
Standard BioTools (LAB) Stock Rebound Leaves Revenue Slide And Losses In Focus - simplywall.stsimplywall.st · Fri, 07 Aug 2026 01:53:53 GMTBlackRock, Inc. Reduces Standard BioTools Inc (LAB) Stake -- Sha - GuruFocusGuruFocus · Thu, 06 Aug 2026 01:33:07 GMTStandard BioTools (NASDAQ: LAB) nets $388M cash from Illumina deal - Stock TitanStock Titan · Wed, 05 Aug 2026 20:12:22 GMTStandard BioTools Sells Mass Cytometry Business and Secures $30 Million Illumina Buyout Ahead of Treeline Merger - citybizcitybiz · Tue, 28 Jul 2026 12:32:40 GMTStandard BioTools (NASDAQ: LAB) nets $30M Illumina buyout, sells mass cytometry arm - Stock TitanStock Titan · Tue, 28 Jul 2026 12:25:42 GMTStandard BioTools Sells Mass Cytometry Business Amid Pending Merger With Treeline Biosciences - Yahoo FinanceYahoo Finance · Tue, 28 Jul 2026 07:00:00 GMTPlanned Sale Targets Continuity for CyTOF, Hyperion Customers - Stock TitanStock Titan · Tue, 28 Jul 2026 07:00:00 GMTStandard BioTools (LAB) plans sale of Mass Cytometry business alongside Treeline deal - Stock TitanStock Titan · Tue, 28 Jul 2026 07:00:00 GMT